Design and Synthesis of a Novel Series of Orally Bioavailable, CNS-Penetrant, Isoform Selective Phosphoinositide 3-Kinase γ Inhibitors (PI3Kγ) with Potential for the Treatment of Multiple Sclerosis (MS).
| Image |  |
|---|---|
| Description | scientific article |
| Author/s | |
| Publication date | May 30, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |